THC Biomed Intl Ltd. | Income Statement
Fiscal year is August-July. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
-
-
59.90
925.30
Cost of Goods Sold (COGS) incl. D&A
0.40
0.30
11.70
46.90
626.80
1,137.40
Gross Income
0.40
0.30
11.70
46.90
567.00
212.10
SG&A Expense
381.10
1,353.70
1,926.00
838.70
1,264.70
2,659.10
EBIT
381.50
1,354.00
1,937.70
-
1,843.20
2,891.30
Unusual Expense
-
61.90
1,069.10
145.00
1,273.10
9,405.30
Non Operating Income/Expense
99.50
2.40
17.40
251.60
22.50
3.60
Interest Expense
89.10
23.30
38.10
47.40
57.50
158.70
Pretax Income
371.10
1,317.60
3,062.10
536.30
604.90
12,458.90
Consolidated Net Income
371.10
1,317.60
3,062.10
536.30
604.90
12,458.90
Net Income
371.10
1,317.60
3,062.10
536.30
604.90
12,458.90
Net Income After Extraordinaries
371.10
1,317.60
3,062.10
536.30
604.90
12,458.90
Net Income Available to Common
371.10
1,317.60
3,062.10
536.30
604.90
12,458.90
EPS (Basic)
0.01
0.01
0.08
0.01
0.01
0.11
Basic Shares Outstanding
43,532.20
103,520.70
40,779.90
89,072.00
102,150.10
112,317.30
EPS (Diluted)
0.01
0.01
0.08
0.01
0.01
0.11
Diluted Shares Outstanding
43,532.20
103,520.70
40,779.90
89,072.00
102,150.10
112,317.30
EBITDA
381.10
1,353.70
1,926.00
839.40
1,753.20
2,692.90
Other Operating Expense
-
-
-
0.70
11.50
20.10
Non-Operating Interest Income
-
0.30
0.20
0.90
0.20
-
About THC Biomed Intl
View Profile
